Mad Money

Cramer's lightning round: Amicus Therapeutics is an ideal spec

Key Points
  • It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

Loading chart...

Quantumscape Corp: "I think you should take the money and run."

Loading chart...

Inmode Ltd: "It sells for incredibly cheap. ... Frankly, I don't get it, and that makes me want to look more into it, not just say buy."

Loading chart...

Amicus Therapeutics Inc: "I think that that stock is an ideal spec."

Loading chart...

Exact Sciences Corp: "They're losing too much money, to be honest. I'm baffled. ... That's what I don't like about it."

Loading chart...

Array Technologies Inc: "I've been looking for a new way to play solar. ... I think Array may be the way."

Loading chart...

National Retail Properties Inc: "I like Realty Income. ... That's been my favorite."

Cramer's lightning round: Amicus Therapeutics is an ideal spec
VIDEO4:0004:00
Cramer's lightning round: Amicus Therapeutics is an ideal spec

Jim Cramer's Guide to Investing

Click here to download Jim Cramer's Guide to Investing at no cost to help you build long-term wealth and invest smarter.

Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com